Guanoxabenz

Guanoxabenz
Names
	IUPAC name 2-{amino}-1-hydroxyguanidine
Identifiers
CAS Number	24047-25-4 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL461343 ;
ChemSpider	7842543 ;
KEGG	D04398 ;
MeSH	Guanoxabenz
PubChem CID	9567831;
UNII	P9HIK5V7WK ;
	InChI InChI=1S/C8H8Cl2N4O/c9-6-2-1-3-7(10)5(6)4-12-13-8(11)14-15/h1-4,15H,(H3,11,13,14)/b12-4+ Key: QKIQJNNDIWGVEH-UUILKARUSA-N ; InChI=1/C8H8Cl2N4O/c9-6-2-1-3-7(10)5(6)4-12-13-8(11)14-15/h1-4,15H,(H3,11,13,14)/b12-4+ Key: QKIQJNNDIWGVEH-UUILKARUBE;
	SMILES Clc1cccc(Cl)c1\C=N\N=C(/N)NO;
Properties
Chemical formula	C8H8Cl2N4O
Molar mass	247.08 g/mol
Pharmacology
ATC code	C02CC07 (WHO)
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). verify (what is ?) Infobox references

Guanoxabenz is a metabolite of guanabenz.^[1]

References

^ Clement, B.; Demesmaeker, M. (1997). "Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2". Drug Metabolism and Disposition. 25 (11): 1266–1271. PMID 9351903.

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.

Zdroj:https://en.wikipedia.org?pojem=Guanoxabenz
Text je dostupný za podmienok Creative Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších podmienok. Podrobnejšie informácie nájdete na stránke Podmienky použitia.

[1] Clement, B.; Demesmaeker, M. (1997). "Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2". Drug Metabolism and Disposition. 25 (11): 1266–1271. PMID 9351903.

[1]